Hank F. Kung Ph.D., serves as the Chief Scientific Advisor and Chairman of the Scientific Advisory Board of Avid Radiopharmaceuticals, Inc. Dr. Kung is regarded as a world leader in research and development of innovative radiopharmaceuticals for diagnosis of brain diseases including Alzheimer's disease and Parkinson's disease. Dr. Kung is the inventor of the radiopharmaceuticals IBZM marketed in Europe and Trodat in clinical development in the U.S. for Parkinson's disease. He has received numerous professional awards, including the Image-Of-The-Year award from American Society of Nuclear Medicine 1996 and 2002 for radiopharmaceuticals used in Parkinson's disease and the Springer award European Journal of Nuclear Medicine in 1997 .
Brain disorders